Eric Fourmaux

507 total citations
8 papers, 389 citations indexed

About

Eric Fourmaux is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Eric Fourmaux has authored 8 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Eric Fourmaux's work include Cell death mechanisms and regulation (3 papers), Heat shock proteins research (3 papers) and Immunotherapy and Immune Responses (2 papers). Eric Fourmaux is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Heat shock proteins research (3 papers) and Immunotherapy and Immune Responses (2 papers). Eric Fourmaux collaborates with scholars based in France, United States and Canada. Eric Fourmaux's co-authors include Arlette Hammann, Carmen Garrido, Aurélie de Thonel, Olivier Micheau, Jean-Paul Paı̈s de Barros, Dominique Thuringer, Anne-Laure Rérole, Éric Solary, Guillaume Wettstein and E. Schmitt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Eric Fourmaux

8 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Fourmaux France	7	289	92	83	62	39	8	389
Adonis Hazoumé France	6	439 1.5×	65 0.7×	124 1.5×	81 1.3×	24 0.6×	7	564
Zarema Albakova Russia	9	313 1.1×	30 0.3×	108 1.3×	83 1.3×	16 0.4×	11	399
Alan J. Situ United States	14	405 1.4×	24 0.3×	62 0.7×	51 0.8×	11 0.3×	20	488
Ryan R. Falsey United States	7	215 0.7×	46 0.5×	38 0.5×	25 0.4×	12 0.3×	10	340
Denny G.A. Johansson Sweden	5	285 1.0×	57 0.6×	55 0.7×	50 0.8×	43 1.1×	5	350
Zhou Yuan United States	8	111 0.4×	75 0.8×	64 0.8×	120 1.9×	27 0.7×	18	315
Chul-Woo Kim South Korea	8	268 0.9×	43 0.5×	36 0.4×	102 1.6×	10 0.3×	12	349
Hardik Patel United States	7	297 1.0×	21 0.2×	71 0.9×	62 1.0×	12 0.3×	8	348
Rakesh Trivedi United States	6	195 0.7×	96 1.0×	22 0.3×	81 1.3×	11 0.3×	6	383
Kengo Tsuda Japan	16	593 2.1×	60 0.7×	30 0.4×	55 0.9×	15 0.4×	30	693

Countries citing papers authored by Eric Fourmaux

Since Specialization

Citations

This map shows the geographic impact of Eric Fourmaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Fourmaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Fourmaux more than expected).

Fields of papers citing papers by Eric Fourmaux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Fourmaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Fourmaux. The network helps show where Eric Fourmaux may publish in the future.

Co-authorship network of co-authors of Eric Fourmaux

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Fourmaux. A scholar is included among the top collaborators of Eric Fourmaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Fourmaux. Eric Fourmaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Chettab, Kamel, Chantel Fitzsimmons, А. В. Новиков, et al.. (2023). A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models. Frontiers in Immunology. 14. 1066402–1066402. 6 indexed citations

Fournet, Guy, Eric Fourmaux, Eva‐Laure Matera, et al.. (2021). Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform. Pharmaceuticals. 14(3). 247–247. 45 indexed citations

Dubuisson, Agathe, et al.. (2019). Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization. Cell Death and Disease. 10(2). 101–101. 6 indexed citations

Thonel, Aurélie de, Adonis Hazoumé, Vitaly Kochin, et al.. (2014). Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells. Cell Death and Disease. 5(1). e1016–e1016. 21 indexed citations

Rérole, Anne-Laure, Jessica Gobbo, Aurélie de Thonel, et al.. (2011). Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy. Cancer Research. 71(2). 484–495. 124 indexed citations

Goloudina, Anastasia R., Arlette Hammann, Eric Fourmaux, et al.. (2011). Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents. Proceedings of the National Academy of Sciences. 109(2). E68–75. 45 indexed citations

Thuringer, Dominique, Arlette Hammann, Eric Fourmaux, et al.. (2010). Transactivation of the Epidermal Growth Factor Receptor by Heat Shock Protein 90 via Toll-like Receptor 4 Contributes to the Migration of Glioblastoma Cells. Journal of Biological Chemistry. 286(5). 3418–3428. 71 indexed citations

Thonel, Aurélie de, Arlette Hammann, Anne‐Laure Joly, et al.. (2009). Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene. 28(37). 3332–3344. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact